Amgen and Adaptive Biotechnologies will work together to identify and develop an antibody therapy for COVID-19 Adaptive aims to screen tens of thousands of antibodies produced by B cells in people who have recovered from COVID-19 and find ones that neutralize the virus that causes it, SARS-CoV-2 Amgen will develop and manufacture the best antibodies to test as therapies Adaptive is also expandinga collaboration with Microsoft to study how T cells respond to the viral infection